Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases

被引：0
作者：
Munoz, M. A. [1 ]
Jurczyluk, J. [1 ]
Skinner, O. P. [1 ]
Preston, A. [1 ]
Ali, N. [1 ]
Palendira, U. [2 ,3 ]
Quinn, J. M. W. [1 ]
Argent, E.
Tangye, S. G. [4 ]
Brown, A. J. [5 ]
Ziegler, J. B. [6 ]
Mehr, S. [7 ]
Rogers, M. [1 ]
机构：
[1] Garvan Inst Med Res, Bone Biol, Darlinghurst, NSW, Australia
[2] Univ Sydney, Centenary Inst, Camperdown, NSW, Australia
[3] Sydney Childrens Hosp, Dept Gen Paediat, Randwick, NSW, Australia
[4] Garvan Inst Med Res, Immunol, Darlinghurst, NSW, Australia
[5] Univ New South Wales, Sch Biotechnol & Biomol Sci, Darlinghurst, NSW, Australia
[6] Sydney Childrens Hosp, Dept Immunol & Infect Dis, Randwick, NSW, Australia
[7] Childrens Hosp Westmead, Dept Immunol & Allergy, Sydney, NSW, Australia
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
320
引用
收藏
页码：391 / 391
页数：1
相关论文
共 50 条
  • [21] Perinatal Onset Mevalonate Kinase Deficiency
    Steiner, Laurie A.
    Ehrenkranz, Richard A.
    Peterec, Steven M.
    Steiner, Robert D.
    Reyes-Mugica, Miguel
    Gallagher, Patrick G.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2011, 14 (04) : 301 - 306
  • [22] Retinitis pigmentosa in mevalonate kinase deficiency
    Balgobind, B
    Wittebol-Post, D
    Frenkel, J
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (06) : 1143 - 1145
  • [23] Mevalonate kinase deficiency: current perspectives
    Favier, Leslie A.
    Schulert, Grant S.
    APPLICATION OF CLINICAL GENETICS, 2016, 9 : 101 - 110
  • [24] Evolutionary hypothesis of the Mevalonate Kinase Deficiency
    Vuch, J.
    Marcuzzi, A.
    Bianco, A. M.
    Tommasini, A.
    Zanin, V.
    Crovella, S.
    MEDICAL HYPOTHESES, 2013, 80 (01) : 67 - 69
  • [25] Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
    Rafiq, Nadia K.
    Lachmann, Helen
    Joensen, Frodi
    Herlin, Troels
    Brogan, Paul A.
    CASE REPORTS IN PEDIATRICS, 2018, 2018
  • [26] Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation
    Marcuzzi, Annalisa
    Crovella, Sergio
    Monasta, Lorenzo
    Brumatti, Liza Vecchi
    Gattorno, Marco
    Frenkel, Joost
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (35) : 5746 - 5752
  • [27] Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
    Y Shinar
    PJ Hashkes
    R Cohen
    A Kessel
    I Tirosh
    S Padeh
    J Arostegui
    A Livneh
    Pediatric Rheumatology, 13 (Suppl 1)
  • [28] Rab GTPases as Physiological Substrates of LRRK2 Kinase
    Seol, Wongi
    Nam, Daleum
    Son, Ilhong
    EXPERIMENTAL NEUROBIOLOGY, 2019, 28 (02) : 134 - 145
  • [29] The enlarging clinical spectrum of mevalonate kinase deficiency
    Bader-Meunier, Brigitte
    Florkin, Benoit
    Sibilia, J.
    Aquaviva, C.
    Hachulla, E.
    Grateau, G.
    Richer, O.
    Farber, M.
    Fischbach, M.
    Hentgen, V.
    Jego, Y.
    Laroche, C.
    Neven, B.
    Lequerre, T.
    Mathian, A.
    Pellier, I.
    Touitou, I.
    Rabier, D.
    Prieur, A. M.
    Cuisset, L.
    Quartier, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 372 - 372
  • [30] Weekly oral alendronate in mevalonate kinase deficiency
    Luca Cantarini
    Antonio Vitale
    Flora Magnotti
    Orso Maria Lucherini
    Francesco Caso
    Bruno Frediani
    Mauro Galeazzi
    Donato Rigante
    Orphanet Journal of Rare Diseases, 8
12345